Sabby Management

Sabby Management

Sabby Management

Suggest edits
Follow us
Terms of Service Privacy Policy Cookie Statement
Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 3

Portfolio

Portfolio Tracker

Add info
Pulse 2.0

Xeris Pharmaceuticals Shares Increase Over 20% Pre-Market: Why It Happened

Xeris Pharmaceuticals
Xeris Pharmaceuticals
the home of AI info

Unum Therapeutics Inc. (UMRX)'s Financial Results Comparing With Minerva Neurosciences Inc ...

Unum Therapeutics
Unum Therapeutics
$85,500,000 IPO
PE HUB

Xeris Pharmaceuticals goes public

Stock markets
Xeris Pharmaceuticals
Xeris Pharmaceuticals
$69,200,000 IPO
PE HUB

VC-backed Unum Therapeutics rolls out IPO

Stock markets Health
Unum Therapeutics
Unum Therapeutics
Xconomy

Unum Therapeutics IPO Raises $69M to Test Universal Cell Therapies

Health Stock markets
Unum Therapeutics
Unum Therapeutics
$15,000,000 Debt financing
FinSMEs

Unum Therapeutics Receives $15M Credit Facility from Square 1 Bank

Unum Therapeutics
Unum Therapeutics
Unum
Unum
$41,000,000 Venture capital (Series C)
Xconomy

Austin Biotech Xeris Names Edick CEO, Raises $41M in Series C Round

Health Funding
Xeris Pharmaceuticals
Xeris Pharmaceuticals
$41,000,000 Venture capital (Series C)
FinSMEs

Xeris Pharmaceuticals Closes $41M Series C Financing

Funding Health